Transplant Diagnostics Market: Current Analysis and Forecast (2021-2027)


Emphasis on Technology [Molecular Assay Technologies (PCR-Based Molecular Assays, Sequencing Based Molecular Assays), Non-Molecular Assay Technologies], Product & Service (Reagents & Consumables, Instruments, Software & Services); Transplant Type (Solid Organ Transplantation Stem Cell Transplantation, Soft Tissue Transplantation, Bone Marrow Transplantation); Application (Diagnostic, Research); End-User (Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes); and Region & Country.







Report ID:



  Get a Free Sample
SKU: UMHE21306 Category:
Report Description
Table of content
Research Methodology

Report Description

Transplant diagnostics are tests used to determine whether the donor and receiver of an organ are compatible before or after transplant. The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing number of organ transplant, and technological advancements in the field of transplant diagnostics. In 2019, the rate of patients having transplanted organs in several nations around the world. During this year, France had a rate of roughly 87 organ transplant patients per million inhabitants. If blood and oxygen are flowing through the organs until the moment of recovery, organ donation can be done by both a deceased and a living donor. The increased rate of organ transplantation is due to the increase in diseases causing severe organ damages. This has been boosting the demand for diagnostic transplants.

Although there are more than 107,453 waiting for organ transplants, there has been a steady rise in the number of donor rates, followed by the deceased donor rate.  For instance, as per Global Observatory on Donation and Transplantation (GODT), number of live kidney donors increased by 3.3%b whereas number of deceased donors increased by 8.1% from 2018 to 2019. This shows the improvement and demand for more diagnostics facilities across the healthcare sector related to transplant. The increase in number of organ donors is expected to be very lucrative for growth and dominance of transplant over the forecast period.

In the last decade, healthcare spending in those countries has remained about in line with total economic growth. Between 2010 and 2019, health spending in the OECD averaged around 8.7% of GDP every year. In the same time span, however, healthcare spending in the United States increased from 16.3 percent to 17.0 percent of GDP.

As per OECD data of 2019, the United States accounted for highest per capita GDP of 17% followed by Switzerland and Germany with GDP of 12.1% and 11.7%, respectively. The improvement in healthcare is expected to boost the market for Transplant Diagnostics Market

Organ transplant worldwide, 2019 (per million population)

Bio-Rad laboratories, Inc., Dorel Industries Inc., F. Hoffman-La Roche Ltd., QIAGEN N.V., Thermo Fisher Scientific Inc., bioMérieux S.A., Immucor, Inc., llumina, Inc., Luminex Corporation, Becton, Dickinson and Company, are some of the prominent players operating in the global Transplant Diagnostics market. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.

Insights Presented in the Report

“Amongst Technology, Molecular Assay Technologies segment holds the major share”

Based on technology, the market is fragmented into molecular assay technologies, and non-molecular assay technologies. Further, the molecular technologies studied into PCR-based molecular assays, sequencing based molecular assays. The molecular assay technologies segment dominated the market with a share of XX% in 2020 and is expected to maintain its dominance during the forecast period owing to the increasing public-private financing for target research efforts and the expanding burden of infectious illnesses.

“Amongst Product & Service, Instruments is anticipated to grow at the highest CAGR during the analyzed period”

Further based on product & service, the market is fragmented into reagents & consumables, instruments, software & services. In 2020, instruments accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period owing to the increasing healthcare expenditures.

Amongst Transplant Type, Solid Organ Transplantation segment holds the major share”

Based on the transplant type, the market is fragmented into solid organ transplantation stem cell transplantation, soft tissue transplantation, and bone marrow transplantation. The solid organ transplantation centers dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period. Furthermore, the segment is also expected to grow at the highest CAGR during the period.

Amongst Application, Diagnostic Application segment holds the major share”

Based on the application, the market is fragmented into diagnostic applications and research applications. The diagnostic applications centers dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period on account of its varied applications in patient profiling and increasing clinical evidence of its efficacy.

Amongst End-User, Independent Reference Laboratories segment holds the major share”

Based on the end-user type, the market is fragmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. The independent reference laboratories dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period owing to the growing number of research & development activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.

“North America signifies one of the largest markets of Transplant Diagnostics Market”

For a better understanding of the market dynamics of the Transplant Diagnostics market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 owing to factors such as highly developed healthcare infrastructure and the availability of skilled professionals. Moreover, the high adoption of personalized medicines, stem cell therapies, and soft tissue transplants are augmenting the regional market growth. Although there are 107,453 of individuals are in the waiting list waiting list in USA but at the same time the number of donors are also increasing at a good pace.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The Transplant Diagnostics Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1Market Definitions 
1.2Objective of the Study
1.4Stake Holders 
1.5Currency Used in Report
1.6Scope of the Global Transplant Diagnostics Market Study
2.1Research Methodology for the Global Transplant Diagnostics Market
 2.1.1Main Objective of the Global Transplant Diagnostics Market
8.1Molecular Assay Technologies
 8.1.1PCR-based molecular assays
 8.1.2Sequencing Based Molecular Assays
8.2Non-molecular Assays Technology
9.1Reagents & Consumables
9.3Software & Services 
10.1Solid organ transplantation
10.2Stem cell transplantation
10.3Soft tissue transplantation
10.4Bone marrow transplantation
11.1Diagnostic application
 11.1.1Pre transplantation diagnostics
 11.1.2Post transplantation diagnostics
11.2Research Application
12.1Independent reference laboratories
12.2Hospitals & transplants ceneters
12.3Research laboratories & Academic institutes
 11.1.1United StatesS
 11.1.3Rest of North America
 11.2.3United Kingdom
 11.2.6Rest of Europe
 11.3.5South Korea
 11.3.6Rest of Asia Pacific
12.1Market Drivers 
12.2Market Challenges
12.3Impact Analysis
14.1Demand Side Analysis
14.2Supply Side Analysis
 14.2.1Top Product Launches
 14.2.2Top Business Partnerships
 14.2.3Top Merger & Acquisitions


18.1Porter’s Five forces analysis
 18.1.1Bargaining power of Supplier
 18.1.2Bargaining power of Buyer
 18.1.3Industry Rivalry
 18.1.4Availability of Substitute
 18.1.5Threat of new Entrants
19.1Bio-Rad laboratories, Inc.
 19.1.1Key Facts 
 19.1.2Business Description
 19.1.3Key Product/Services Offerings
 19.1.4Growth Strategy
 19.1.5SWOT Analysis
 19.1.6Key Financials Split Overview of Bio-Rad laboratories, Inc.
 19.1.7Recent Developments Launch Expansion and Investments and Acquisition
19.2Dorel Industries Inc.
19.3F. Hoffman-La Roche Ltd.
19.4QIAGEN N.V. 
19.5Thermo Fisher Scientific Inc.
19.6 bioMérieux S.A. 
19.7Immucor, Inc. 
19.8llumina, Inc. 
19.9Luminex Corporation
19.1Becton, Dickinson and Company

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global Transplant Diagnostics Market were the three major steps undertaken to create and analyze the adoption of organ and tissue transplants for the different diseases across major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Transplant Diagnostics sector. Post assumption and validation of market numbers through primary interviews, we employed a top-down/Bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detailed secondary study was conducted to obtain the historical market size of the Transplant Diagnostics through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Transplant Diagnostics market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments for major regions. Major segments included in the report are therapy, application, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of Transplant Diagnostics in every region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Transplant Diagnostics. Further, we conducted factor analysis using dependent and independent variables such as increasing chronic disease, growing geriatric population. A thorough analysis was conducted for demand and supply-side scenario considering top partnerships, merger and acquisition, business expansion, and product launches in the Transplant Diagnostics industry across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Transplant Diagnostics market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e. top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (USD) and the adoption rate of Transplant Diagnostics across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the Transplant Diagnostics market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Transplant Diagnostics market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of technology, product & service, transplant type, application, and end-user of the Transplant Diagnostics market.

Main Objective of the Transplant Diagnostics Market Study

The current & future market trends of Transplant Diagnostics were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of Transplant Diagnostics in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of technology, product & service, transplant type, application, and end-user
  • Define and analysis of the regulatory framework for the Transplant Diagnostics industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the Transplant Diagnostics market for the major region
  • Major regions studied in the report include North America (the United States and Canada), Europe (Germany, France, Italy, Spain, and United Kingdom), Asia-Pacific (China, Japan, India and Australia), and Rest of the World
  • Company profiles of the Transplant Diagnostics market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry